DNTHDianthus Therapeutics, Inc.
$76.91+114% 1Y
$76.91
$32.9252 weeks$115.67
Is the price fair?
What DNTH's price assumes
Dianthus Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 2113× revenue.
2113
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 8.72
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 1914
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 8.72
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 1914
- Market capitalisation55.9 million shares, counted Aug 3, 2026
- $4.30B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks